Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for October 14th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 14th:

Boise Cascade Company (BCC - Free Report) : This wood products manufacturing company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.

Boise Cascade’s shares gained 3.6% over the last one month in contrast the S&P 500 declined 0.9%. The company possesses a Momentum Score of A.

Crocs, Inc. (CROX - Free Report) : This shoe manufacturing company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 60 days.

Crocs, Inc. Price and Consensus

Crocs, Inc. Price and Consensus

Crocs, Inc. price-consensus-chart | Crocs, Inc. Quote

Crocs’ shares gained 8.7% over the last one month in contrast the S&P 500 declined 2%. The company possesses a Momentum Score of A.

Square Enix Holdings Co., Ltd. (SQNXF - Free Report) : This shipping company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.8% over the last 60 days.

Square Enix Holding’s shares gained 16% over the last one month. The company possesses a Momentum Score of A.

Taylor Morrison Home Corporation (TMHC - Free Report) : This home building company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 0.4% over the last 60 days.

Taylor Morrison Home’s shares gained 4.1% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>